Basic Information
Volulyte Solution for Infusion 6%
INFUSION, SOLUTION
Regulatory Information
SIN13893P
December 2, 2010
General Sale List
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
Company Information
Active Ingredients
Strength: 6.02g
Strength: 60.00g
Strength: 0.30g
Strength: 0.30g
Strength: 4.63g
Detailed Information
Contraindications
**4.3 Contraindications** Do not use HES products in: - patients with known hypersensitivity to hydroxyethyl starch - patients with sepsis - patients with renal failure with oliguria or anuria not related to hypovolaemia - patients receiving dialysis treatment - patients with intracranial bleeding - clinical conditions where volume overload (hyperhydration) is a potential problem, especially in cases of pulmonary oedema and congestive cardiac failure - patients with severe hyperkalaemia, severe hypernatraemia or severe hyperchloraemia - patients with severe liver disease - patients with pre-existing coagulation or bleeding disorders
Indication Information
**4.1 Therapeutic indications** Volulyte is indicated for the treatment and prophylaxis of hypovolaemia in adults and children. It is not a substitute for red blood cells or coagulation factors in plasma.